綠城中國(03900.HK)將贖回共5億美元證券
格隆匯1月3日丨綠城中國(03900.HK)公吿,公司的全資附屬公司冠誠控股有限公司作為發行人已向系列一證券(即於2022年可贖回的高級永久資本證券)持有人、系列一證券受託人、系列二證券(於2022年可贖回的高級永久資本證券)持有人及系列二證券受託人發送通知,知會受託人,各系列2019證券將於贖回日期按各自贖回價悉數贖回。
於本公吿日期,系列一證券尚未償付的本金額為4億美元,系列二證券尚未償付的本金額為1億美元。
於贖回日期贖回所有2019證券後,所有2019證券將予以註銷。本次贖回完成後,將再無已發行尚未償付的2019證券。2019證券於2019年2月11日於香港聯合交易所有限公司上市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.